Teng-Chieh Yang

Title: Innovations of Teng-Chieh Yang in Glycation Prediction

Introduction

Teng-Chieh Yang is an accomplished inventor based in Stratford, CT (US). He has made significant contributions to the field of therapeutic biomolecules, particularly in the area of glycation prediction and modulation. His innovative work has the potential to enhance the efficacy of therapeutic treatments.

Latest Patents

Yang holds a patent titled "Methods for predicting and modulating glycation of a protein." This patent outlines methods for predicting the glycation percentage of an amino acid in a therapeutic biomolecule. The process involves determining rates for a de-glycation reaction at various temperatures and using this data to predict glycation percentages over time. This innovation is crucial for maintaining the stability and effectiveness of therapeutic biomolecules.

Career Highlights

Teng-Chieh Yang is currently associated with Regeneron Pharmaceuticals, Inc., where he applies his expertise in biochemistry and molecular biology. His work focuses on developing methods that can significantly impact the pharmaceutical industry by improving the shelf-life and potency of therapeutic biomolecules.

Collaborations

Yang collaborates with notable colleagues, including Haibo Qiu and Xiaobin Xu. Their combined efforts contribute to advancing research and development in the field of therapeutic biomolecules.

Conclusion

Teng-Chieh Yang's innovative approaches to predicting and modulating glycation in proteins represent a significant advancement in therapeutic biomolecule research. His contributions are poised to make a lasting impact on the pharmaceutical industry.